# Shandong Ruiying Pioneer Pharmaceutical Co., Ltd – FDA Inspection, Mar 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/shandong-ruiying-pioneer-pharmaceutical-co-ltd/25050831-a9e8-4a77-aa7c-4521a632078f
Source feed: FDA_Inspections

> FDA inspection 1086433 of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd, March 22, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086433
- Company Name: Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Inspection Date: 2019-03-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1264014 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/shandong-ruiying-pioneer-pharmaceutical-co-ltd/1cac6f1a-546d-4bc3-85ba-71da7351dbb6)
- FDA Inspection 920919 - 2015-03-27
- FDA Inspection 707439 - 2010-09-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)

Company: https://www.keypedia.com/companies/shandong-ruiying-pioneer-pharmaceutical-co-ltd/574c4f09-5a4e-4428-b84d-cb139c05ff9b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
